摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(1,2,3,9-tetramethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide | 143956-83-6

中文名称
——
中文别名
——
英文名称
N-(1,2,3,9-tetramethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide
英文别名
N-acetylcolchinol methyl ether;NSC 51046;(+/-)-N-(3,9,10,11-tetramethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamide;N-(3,9,10,11-tetramethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamide;(+/-)-N-(3,9,10,11-Tetramethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamid;(+/-)-N-(3,9,10,11-Tetramethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamid; N-Acetyl-dl-colchinol-methylaether;Acetamide, N-(6,7-dihydro-3,9,10,11-tetramethoxy-5H-dibenzo(a,c)cyclohepten-5-yl)-, (S)-;N-(5,13,14,15-tetramethoxy-8-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acetamide
N-(1,2,3,9-tetramethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide化学式
CAS
143956-83-6;867192-70-9
化学式
C21H25NO5
mdl
——
分子量
371.433
InChiKey
FEPNCXXZWLXIHV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    599.0±50.0 °C(Predicted)
  • 密度:
    1.21±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    27
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    66
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Allocolchicines─Synthesis with Electro-organic Key Transformations
    作者:Dennis Pollok、Florian U. Rausch、Sebastian B. Beil、Peter Franzmann、Siegfried R. Waldvogel
    DOI:10.1021/acs.orglett.2c01084
    日期:2022.6.3
    saffron are potentially active ingredients for cancer therapy. A concise protocol for the sustainable synthesis of allocolchicines using up to two electro-organic key transformations is demonstrated. This straightforward synthesis of N-acetylcolchinol methyl ether in a five-step protocol was adopted using protecting groups to enable access to N-acetylcolchinol and the phosphate derivative ZD6126.
    草甸藏红花中天然存在的秋水仙碱和别秋水仙碱是癌症治疗的潜在活性成分。演示了使用多达两个有机电键转换可持续合成别秋水仙素的简明方案。这种在五步方案中直接合成N-乙酰秋水仙醇甲基醚的方法采用了保护基团,以便能够获得N-乙酰秋水仙醇和磷酸盐衍生物 ZD6126。
  • 10.1021/acs.orglett.4c02047
    作者:Xu, Zelin、Zhou, Meichen、Feng, Yuer、Han, Ziyu、Li, Yaoyao、Yang, Guang、Wang, Xin、Zhang, Kun、Liu, Shuangwei
    DOI:10.1021/acs.orglett.4c02047
    日期:——
    6-8-6 carbon ring systems are present in numerous biologically active natural molecules. However, simple and efficient synthetic approaches to these scaffolds remain challenging. Herein, we report a versatile strategy for constructing these ring systems via Fe(NO3)3-triggered radical arylation of arenes starting from cyclopropanols. This synthetic utility has been demonstrated in the synthesis of the natural
    三环6-7-6和6-8-6碳环系统存在于许多生物活性天然分子中。然而,这些支架的简单有效的合成方法仍然具有挑战性。在此,我们报告了一种通过 Fe(NO 3 ) 3触发从环丙醇开始的芳烃自由基芳基化来构建这些环系统的通用策略。这种合成效用已在天然产物N-乙酰秋水仙醇-O-甲基醚的合成中得到证实。
  • Application of Aryl Siloxane Cross-Coupling to the Synthesis of Allocolchicinoids
    作者:W. Michael Seganish、Philip DeShong
    DOI:10.1021/ol061413t
    日期:2006.8.1
    In this communication, we report a new approach to the allocolchicine carbocyclic skeleton based upon an aryl siloxane coupling reaction and a phenanthrol ring expansion. These key steps allow for the selective functionalization of every carbon within the carbocyclic framework. The siloxane coupling-phenanthrol sequence was applied to the synthesis of two allocolchicinoids, including the first fully synthetic approach to N-acetyl colchinol-O-methyl ether (NCME).
  • Diversity Oriented Synthesis of Allocolchicinoids with Fluoro and/or Oxygen Substituent(s) on the C-Ring from a Single Common Intermediate
    作者:Keita Takubo、Kazunori Furutsu、Takafumi Ide、Hiroyuki Nemoto、Yuko Ueda、Kazutake Tsujikawa、Takashi Ikawa、Takehiko Yoshimitsu、Shuji Akai
    DOI:10.1002/ejoc.201501624
    日期:2016.3
    Allocolchicinoids, with a distinct polyoxygenated dibenzocycloheptane skeleton, attract much attention as potential candidate anticancer drugs. In this study, eight C-ring fluorinated analogues of allocolchicinoids, seven C-ring oxygen-substituted analogues, and known compounds N-acetylcolchinol and NSC 51046 were synthesized as racemates from a single common intermediate by using either the deoxy
    别秋水仙素类化合物具有独特的多氧化二苯并环庚烷骨架,作为潜在的候选抗癌药物备受关注。在这项研究中,通过使用脱氧氟化/迁移多米诺反应或从单一的常见中间体合成了 8 种别秋水仙素的 C 环氟化类似物、7 种 C 环氧取代类似物和已知化合物 N-乙酰秋水仙酚和 NSC 51046 作为外消旋物。酸促进迁移是关键步骤。在获得的产品中,一些氟化衍生物强烈抑制前列腺 DU145 和胰腺 Panc 1 癌细胞系的生长,其功效与 N-乙酰秋水仙醇和 NSC 51046 相当或更好。它们对非癌性肿瘤的毒性也较低细胞系比已知的化合物。
  • Windaus, 1919, p. A,No.16,S.10
    作者:Windaus
    DOI:——
    日期:——
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

别秋水仙碱 N-乙酰基秋水仙醇甲基醚 ANG 453; N-[(5S)-6,7-二氢-9,10,11-三甲氧基-3-(磷酰氧基)-5H-二苯并[a,c]环庚烯-5-基]乙酰胺 N-[(5S)-3-(2-tert-butoxycarbonylethylcarbamoyl)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[3-amino-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[3-((N-benzyloxycarbonylalanyl)amino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-3-(2-morpholinoethoxycarbonyl)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-3-(2-morpholinoethoxy)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-(1,2,3,9,10-pentamethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide N-(10-fuoro-9-hydroxy-1,2,3-trimethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl ethyl hydrogen phosphate N-[(5S)-3-phenoxycarbonyloxy-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl hydrogenmethylphosphonate 4-[([(5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl]oxycarbonyl)amino]butanoic acid 4-[([(5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl]aminocarbonyl)amino]butanoic acid 5-[{(5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl}oxycarbonyl]pentanoic acid N-[(5S)-3-(2,3-epoxypropoxy)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-(6-cyano-7-hydroxy-6-(ethoxymethyl)-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)benzamide N-(6-cyano-7-hydroxy-6-(methoxymethyl)-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)benzamide N-(6-cyano-3-fluoro-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5Hdibenzo[a,c][7]annulen-5-yl)benzamide ethyl 5-benzamido-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5Hdibenzo[a,c][7]annulene-6-carboxylate ethyl 5-benzamido-6-(ethoxymethyl)-7-hydroxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene-6-carboxylate N-(6-cyano-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)furan-2-carboxamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl hydrogensulphate N-[(5S)-3-(N,N-dimethylaminoacetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-9,10,11-trimethoxy-3-([(3-morpholinopropyl)amino]carbonylamino)-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-3-phenoxycarbonylamino-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-N-(3morpholinopropyl)-6,7-dihydro-5H-dibenzo[a,c]cycloheptene-3-carboxamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl methyl carbonate N-((1S)-2''-(8-(metoxycarbonyl)octyl)-1',2',3'-trimetoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(pyridin-2-yl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(2-hydroxyethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(acetoxymethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-((diethylamino)methyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(1-hydroxycyclopentyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(hydroxymethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(1-hydroxyethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide 1'-bromo-2',3',4'-trimethoxybenzo[5',6':4,5]-1H-(aR,1S)-1-acetamido-6,7-dihydrocyclohepta[3, 4-f]-1H-2-hydroxymethylindole 2-chloro-N-(6-cyano-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5Hdibenzo[a,c][7]annulen-5-yl)benzamide (R)-(+)-N-acetylolchinol 5-[N'-(3,5-difluorophenylacetyl)-L-alaninyl]amino-5,7-dihydro-6H-dibenzo[a,c]cyclohepten-6-ol N-(3,9,10,11-tetramethoxy-7-oxo-6,7-dihydro-5H-dibenzo [a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide (S)-7-acetamido-6,7-dihydro-1,2,3-trimethoxy-7H-dibenzocycloheptene N-(2-iodo-3,9,10,11-tetramethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamide N-(9,10-dimethoxy-7-oxo-6,7-dihydro-5H-dibenzo[a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide N-(9-hydroxy-1,2,3-trimethoxy-5,6-dihydro-7H-di-benzo[a,c][7]annulen-7-yl)acetamide N-(1,2,3,9-tetramethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide N-(3-hydroxy-9,10-dimethoxy-7-oxo-6,7-dihydro-5H-dibenzo[a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide N-(3-hydroxy-9,10,11-trimethoxy-7-oxo-6,7-dihydro-5H-dibenzo[a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide N-(3-hydroxy-2-iodo-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamide